Medicinal cannabis prescriptions in Australia are issued by registered medical practitioners within a regulated clinical framework.
Access is not available through general retail and requires an individual assessment.
To better understand how access works in Australia, it is useful to review the pathways involved in obtaining a prescription.
Medicinal cannabis prescribing is governed by national regulatory systems designed to ensure appropriate oversight.
Practitioners may prescribe through:
Special Access Scheme (SAS)
Authorised Prescriber pathways
These frameworks ensure that prescribing decisions are made based on clinical judgement.
Patients often review medicinal cannabis access pathways in Australia to understand how prescriptions are issued.
A prescription can only be issued following an assessment conducted by a qualified practitioner.
This includes:
reviewing medical history
assessing current treatments
evaluating suitability
This forms part of a structured consultation process used to determine whether this approach may be appropriate.
The consultation pathway provides a structured approach to assessment and decision-making.
Consultations may be conducted via telehealth, allowing patients across Australia to access practitioners remotely.
Understanding the consultation pathway can help clarify how these steps are managed.
Not all patients will be considered suitable.
Access is subject to clinical assessment and regulatory requirements.
Understanding the consultation and prescribing pathway is the first step.